Investors and Media
Press Releases
May 20, 2026
Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference
May 15, 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
April 29, 2026
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
April 17, 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2026
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
March 31, 2026
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
March 13, 2026
